SCHEMBL6541950

SCHEMBL6541950

Nc1nc(/C(=N/OC(c2ccccc2)(c2ccccc2)c2ccccc2)C(=O)N[C@@H]2C(=O)N3C(C(=O)OC(c4ccccc4)c4ccccc4)=C(Cl)CS[C@@H]23)c(Cl)s1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.48
▸ HSD17B10 Q99714 6/20 0.48
▸ TDP1 Q9NUW8 6/20 0.48
▸ KDM4E B2RXH2 4/20 0.48
▸ MAPT P10636 4/20 0.48
▸ HPGD P15428 3/20 0.48
▸ KMT2A Q03164 3/20 0.48
▸ CYP3A4 P08684 3/20 0.48
▸ NR1I2 O75469 3/20 0.48
▸ MEN1 O00255 2/20 0.48
▸ CYP2C9 P11712 2/20 0.48
▸ SLC15A2 Q16348 2/20 0.48
▸ LMNA P02545 2/20 0.48
▸ ADORA3 P0DMS8 1/20 0.48
▸ CTDSP1 Q9GZU7 1/20 0.48
▸ HIF1A Q16665 1/20 0.48
▸ BLM P54132 1/20 0.39
▸ CYP2C19 P33261 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ ADRA1A P35348 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6542342 0.93 ALDH1A1 (0.41) ALDH1A1HSD17B10TDP1KDM4EMAPT
SCHEMBL6243253 0.90 ALDH1A1 (0.39) ALDH1A1HSD17B10TDP1KDM4EMAPT
SCHEMBL11375641 0.90 ALDH1A1 (0.50) ALDH1A1HSD17B10TDP1KDM4EMAPT
SCHEMBL11375639 0.90 ALDH1A1 (0.50) ALDH1A1HSD17B10TDP1KDM4EMAPT
SCHEMBL6238490 0.90 TDP1 (0.51) ALDH1A1HSD17B10TDP1KDM4EMAPT
SCHEMBL6238496 0.90 TDP1 (0.51) ALDH1A1HSD17B10TDP1KDM4EMAPT
SCHEMBL6543084 0.89 KCNH2 (0.39) ALDH1A1HSD17B10TDP1KDM4EMAPT
SCHEMBL6543086 0.89 KCNH2 (0.39) ALDH1A1HSD17B10TDP1KDM4EMAPT
SCHEMBL14174240 0.88 KDM4E (0.33) ALDH1A1HSD17B10TDP1KDM4EMAPT
SCHEMBL3394035 0.88 KDM4E (0.33) ALDH1A1HSD17B10TDP1KDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1320533-A4 PRODRUGS OF A 7-ACYLAMINO-3-HETEROARYLTHIO-3-CEPHEM CARBOXYLIC ACID ANTIBIOTIC ESSENTIAL THERAPEUTICS INC (US) 2004-12-15 — — EP disclosed
US-6723716-B1 BACTERICIDE FOR STAPHYLOCOCCUS ESSENTIAL THERAPEUTICS, INC. 2004-04-20 — — US disclosed
EP-1320533-A1 PRODRUGS OF A 7-ACYLAMINO-3-HETEROARYLTHIO-3-CEPHEM CARBOXYLIC ACID ANTIBIOTIC Essential Therapeutics, Inc. (US) 2003-06-25 — — EP disclosed
WO-2002024708-A1 PRODRUGS OF A 7-ACYLAMINO-3-HETEROARYLTHIO-3-CEPHEM CARBOXYLIC ACID ANTIBIOTIC ESSENTIAL THERAPEUTICS, INC. (US) 2002-03-28 — — WO disclosed
EP-0874854-B1 CEPHALOSPORIN ANTIBIOTICS MICROCIDE PHARMACEUTICALS INC (US) 2001-12-12 — — EP disclosed
EP-1059293-A1 Novel amino chlorothiazole compounds Microcide Pharmaceuticals, Inc. (US) 2000-12-13 — — EP disclosed
US-6087355-A A THERAPEUTIC BACTERICIDE COMPOSITION FOR TREATING A METHICILLIN-RESISTANT, VANCOMYCIN-RESISTANT, OR AMPICILLIN-RESISTANT BACTERIAL INFECTION MICROCIDE PHARMACEUTICALS, INC. (US) 2000-07-11 — — US disclosed
US-6066630-A ACTIVE AGAINST ANTIBIOTIC RESISTANT BACTERIA MICROCIDE PHARMACEUTICALS, INC. (US) 2000-05-23 — — US disclosed
US-6057312-A TREATING ANTIBIOTIC RESISTANT BACTERIAL INFECTIONS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-05-02 — — US disclosed
US-6030965-A WIDE SPECTRAM ANTIBIOTICS MICROCIDE PHARMACEUTICALS, INC. (US) 2000-02-29 — — US disclosed
US-6025352-A Cephalosporin antibiotics MICROCIDE PHARMACEUTICALS, INC. (US) 2000-02-15 — — US disclosed
Send feedback